Centrus Energy Corp vs Xylem, Inc. — how do they compare? Centrus Energy Corp trades at $142.44 (market cap $2.91B), while Xylem, Inc. trades at $102.71 (market cap $23.81B). The key difference: Xylem, Inc. is far larger — about 8.2× Centrus Energy Corp's market cap, and Xylem, Inc. pays a 1.69% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 29 Days and Xylem, Inc. for 50 Days on average.
| LEU | XYL | |
|---|---|---|
Market Cap | $2.91B | $23.81B |
Volume | 903,777 | 2,234,713 |
Sector | Energy | Industrials |
52-Week High | $436.00 | $152.95 |
52-Week Low | $138.18 | $100.92 |
Typical Hold Time | 29 Days | 50 Days |
Enterprise Value | $2.22B | $25.59B |
Dividend Yield | — | 1.69% |
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $142.09, down 3.43% on the day, with technical indicators showing a bearish trend. The company reported mixed quarterly results, missing Q4 2025 EPS estimates but beating in Q1 and Q2 2026. Recent news highlights Centrus as a key player in the nuclear fuel supply chain, securing multiple HALEU contracts amid growing nuclear energy demand. Valuation metrics appear elevated with a P/E of 75.18 and P/S of 6.68, while profitability metrics show a net income margin of 10.23% and ROE of 8.05%.
The outlook for LEU is cautiously optimistic, supported by strategic positioning in the nuclear fuel market and recent contract wins. However, high valuation multiples and recent earnings volatility present risks. Analyst consensus is mixed with 46% buy ratings and a $218.10 price target, suggesting potential upside if execution improves. Key risks include execution challenges, competitive pressures, and dependence on nuclear energy policy support.
Xylem (XYL) trades at $101.99, up 0.16% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.46 surpassing the $1.35 estimate. Revenue grew to $9.04B in 2025, and net income margin improved to 10.59%. Recent developments include a $1.5B senior note offering to fund acquisitions and the appointment of a new CFO.
The outlook is supported by solid fundamentals and analyst optimism, with a consensus price target of $149.13 implying significant upside. However, risks include China market weakness and higher debt from recent acquisitions. The stock offers a dividend yield with a $0.43 per share payout declared for Q3 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →